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From 1972 to 1979 intra aortic balloon pumping (IABP) was attempted in 181 patients; catheter
insertion failed in 13 (8%). More complications occurred with prolonged treatment but all three lethal
complications (2%) were related to catheter insertion.
Seventy-six patients had clinical cardiogenic shock after myocardial infarction (CSM1). Haemo-
dynamically, 23 were classified as preshock: 15 (66%) could be weaned, 12 (53%) survived over 3 months;
whereas only 27/51 patients (51%) haemodynamically classified as shock could be weaned and 21
(40%) survived over 3 months.
Of forty-two patients with refractory angina at rest, 41 had prompt relief of pain after IABP, and
subsequently underwent coronary artery bypasss grafting (CABG). Perioperative infarction rate was 8%
(4/41), perioperative mortality was 7% (3/41). Total infarction rate was 11% (5/42), and total mortality 7%
(3/41).
Pain relief was prompt in 14/17 patients (82%) with refractory angina after infarction. Pain persisted in
three patients: all three sustained an infarction, one died. Two patients were excluded from surgery. Twelve
patients underwent CABG; none died, none developed MI.
In eight patients persistence of pain suggested a slowly evolving MI, IABP abolished pain in seven.
Conclusion: IABP has demonstrated its efficacy both in pump failure and in refractory ischaemia.
However, its use is not without risks.
The effect of intra aortic balloon pumping (IABP) is which is related to myocardial oxygen consump-
twofold!'!. The abrupt presystolic balloon deflation tiont1'4! is termed the endocardial viability ratio
decreases afterload, while the post systolic balloon (EVR)t'l. EVR has been regarded a reflection
inflation enhances coronary perfusion pressure, of this balance between oxygen availability and
which is the major determinant of coronary blood consumption,
flow in the presence of critical stenosis!2" 3L The clinical use of IABP has been advocated for
Reduction of afterload increases stroke volume cardiogenic shock following acute myocardial in-
and ejection fraction, and decreases wall tension farction (CSMI) and severe left ventricular failure
and preload, and thus oxygen consumption. It has (LVF) after acute infarction!5-141, with and without
even been suggested, that counterpulsation may mechanical defects, for angina pectoris at rest
open dormant collateral channelsl'l, and that IABP completely refractory to medical therapy!15-161, for
increases flow to the subendocardium by augment- severe LVF and cardiopulmonary bypass depen-
ing existing collateral circulation!'!. dence following open heart surgery!'7!, for LVF of
Afterload reduction reduces oxygen demand; varying aetiological background!'8!, for life threat-
diastolic augmentation increases oxygen avail- ening cardiac arrhythmias refractory to antiarrhy-
ability. The ratio of the Diastolic Pressure Time thmic therapy, and as a supportive measure
Index (DPTI) representing myocardial blood in critically ill cardiac patients undergoing major
flow!'!, and the Systolic Time Tension Index (TTI), surgery!'9!.
Coronary care has entered the era of infarct size
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Figure 1 Myocardial Infarction Research Unit (MIRU) classification.
first transmural anterior myocardial infarction on
left ventricular function, an interesting but uncon-
trolled pilot observation was recently published by
Leinbach et alP°-2li, who applied the IABP to
patients with acute anterior infarctions without
cardiogenic shock.
It is the purpose of this report to present the
experience with IABP from the coronary care unit
of the Thoraxcenter, Rotterdam, over the period
1972-1979.
The indications for IABP have been: CSMI and
severe LVF following acute myocardial infarction,
angina at rest completely refractory to medical
therapy, post infarct (<2 weeks) angina at rest
refractory to medical therapy and the suspicion of a
slowly evolving myocardial infarction. The IABP
was also used for other indications in our insti-
tution: cardiopulmonary bypass dependence fol-
lowing open heart surgery, intractable LVF in
acute viral myocarditis or in septic shock and in
patients with large ventricular aneurysms, in whom
cardiac surgery was contemplated. These indi-
cations will not be discussed here.
Methods
A three-lumen AVCOthane 40 or 20 cm3 balloon
catheter was introduced into the femoral artery
with a side arm graft!"), or later through a
transverse incision with sutures directly around the
catheter, and connected with an AVCO 7 or 10
IABP console. All patients were monitored with
Swan Ganz thermodilution catheters!"] and, in
cases of hypertension or hypotension an arterial
line in the left radial artery. All patients with
indwelling catheters were anticoagulated with
Heparin (20000-30000 units i.v. 24 h"1).
DEFINITIONS AND APPROACH
(1) Cardiogenic shock and severe left ventricular
failure following acute myocardial infarction
In 1972 we adopted the original Myocardial
Infarction Research Unit (MIRU) classification for
left ventricular function as suggested by Leinbach et
alX^ (Fig. 1). Originally, patients in CSMI MIRU
class IV were candidates for treatment with IABP.
However, it soon became apparent that the ma-
jority of patients with pulmonary capillary wedge
pressures (PCWP) greater than 18 mmHg and
stroke work index (S.W.I.=the product of stroke
index, S.I., and mean arterial blood pressure,
M.A.P.) between 1200 and 2000 ml mmHg M"2
rapidly progressed into MIRU class IV with
medical therapy alone. Most progressed within one
day, and required treatment with IABP. On the
other hand, patients who had a PCWP lower than
18 mmHg associated with a S.W.I, below 2000 ml
mmHg M-2 benefitted from medical therapy and
from i.v. volume expanders, and did not require
IABP.
These observations caused us to extend our
indication for IABP (Fig. 1, hatched area), to all
patients who had a PCWP greater than 18 mmHg
and a S.W.I, lower than 2000 ml mmHg M"2,
together with the clinical signs of left ventricular
failure (low blood pressure, cool clammy skin,
mental dullness, pulmonary rales and urinary
production <40mlh- ') . Additional medical
therapy in these patients and in those with shock
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Figure 2 Approach in angina at rest.
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(MIRU class IV) consisted of digitalis, diuretics,
dopamine or dobutamine and nitroprusside. The
therapy with IABP was maintained until a haemo-
dynamically stable condition had been reached
with the patient on oral medication alone.
After haemodynamic stability had been
achieved, left ventricular angiography and coron-
ary arteriography were performed. Surgery was
undertaken only for reparable mechanical lesions.
The weaning from IABP consisted of a stepwise
reduction in the ratio of assisted to not assisted
beats, at 4 hourly intervals (1:2, 1:4, 1:8), with
subsequent removal of IABP in the absence of
haemodynamic deterioration.
(2) Unstable angina pectoris, with ischaemic
attacks at rest (Fig. 2)
Patients with angina at rest with transient ST or
T wave changes but without significant cardiac
enzyme elevation or new Q wave formation, were
kept at bedrest in the coronary care unit.
Haemodynamic monitoring during and after
pain included heart rate, systemic blood pressure,
pulmonary capillary wedge pressure or diastolic
pulmonary artery pressure and cardiac output.
During and following every attack of pain a twelve
lead ECG was registered and, with persisting pain,
repeated at 15 min intervals. Six hours after every
attack of pain the cardiac enzymes (CPK, CPK-
MB, cr-HBDH) were determined. After a sedative,
preferably diazepam (5-10 mg orally 8 h~'), iso-
sorbide dinitrate (5 mg sublingually every 2 h) was
given and the i.v. administration of propranolol
(1-10 mg, at ^ lmgmin- ' ) started. Propranolol
was given until a heart rate of <60 min"1 had been
reached. An oral maintenance dosage (40-800 mg
24 h~') was then instituted. When propranolol was
"contra-indicated because of lung disease a more
selective /?-blocker might be chosen. In later cases
we routinely added the new calcium antagonist,
nifedipine, when /?-blockers alone failed to control
angina at rest.
If the patient was still symptomatic after 8 h of
medical therapy, treatment was considered unsuc-
cessful. For another 0-16 h intensive medical
therapy was given but he was a candidate for
emergency coronary angiography and coronary
artery bypass grafting (CABG). When despite
medical therapy including i.v. nitroglycerin
breakthrough angina occurred, the IABP was intro-
duced. Directly following CABG the IABP was
removed unless there were indications for continu-
ation. Patients with post infarct angina at rest were
treated essentially in the same fashion. We did not
recommend urgent coronary artery bypass grafting
for patients cooled oft" by medical means, although
many of these may require elective surgery sooner
rather than later, depending on the extent of their
coronary artery diseasel"). Patients who developed
an acute infarction despite these measures were
treated conservatively. We discontinued propran-
olol only if cardiac or pulmonary problems arose
from its use.
(3) Slowly evolving myocardial infarction
Occasionally one is confronted with patients who
have persisting ischaemic pain more than 12 h after
their myocardial infarction, refractory to medical
therapy, but without new ECG-changes. These
patients may have mild left ventricular failure
(MIRU class II) or frequent ventricular arrhythmias
suggesting ventricular irritability due to prolonged
ischaemia. In this group we considered the IABP
the definitive therapeutic measure to reduce
ischaemic pain, and we did not consider coronary
artery bypass grafting.
Results (Table 1)
From September, 1972 to March 1979, 168
patients with unstable angina or myocardial infarc-
tion were treated with the IABP. In 13 more
patients, introduction of the balloon catheter failed
(8%). Of the total of 168 patients, 50 (29%) died
during treatment, 16 died within three months
(10%), and 102 (61%) survived over three months.
Duration of treatment with IABP was less than five
days in 87 patients, 5-10 days in 34 patients and
exceeded ten days in 47 patients. Forty-six compli-
cations occurred in 168 patients: thrombocyto-
paenia, which was a common feature in patients
pumped over five days, never caused trouble, and
was therefore not considered to be a complication.
Prolonged use of the IABP was associated with
more complications. All lethal complications how-
ever, were related to balloon catheter insertion and
no fatal complications resulted from prolonged
treatment with the IABP (up to 46 days). In 3/168
(2%) patients death was attributable to the IABP: in
two patients with CSMI, dying within 24 h, autopsy
revealed dissection of the aorta. Trapping of gas in
a kinked balloon may have contributed to death in
one patient who died during CABG.
Two more dissections were encountered: one
patient with CSMI died of intractable arrhythmias
nine days after insertion of the balloon catheter.
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Table 1 Results IABP1972-1979 (168 patients)
Indication Duration IABP Deaths on IABP Deaths < 3 months Survival > 3 months Total
CSMI
Angina at rest despite
medical treatment
Post infarct angina
at rest despite
medical treatment
Slowly evolving
myocardial infarction
Postoperative CABG+
aneurysmectomy
Postoperative valve
replacement
Miscellaneous
< 5 days
5-10 days
> 10 days
Total
< 5 days
5-10 days
> 10 days
Total
< 5 days
5-10 days
> 10 days
Total
< 5 days
5-10 days
> 10 days
Total
< 5 days
5-10 days
> 10 days
Total
< 5 days
5-10 days
> 10 days
Total
< 5 days
5-10 days
> 10 days
Total
29
4
1
34
—
1
1
—
5
5
5
5
3
1
1
5
Total 50
1
1
1
15
2
8
23
33
27
8
4
39
5
5
5
15
1
4
3
2
1
1
2
103
32
15
29
76
30
8
4
42
5
6
6
17
1
4
3
168
Failures to insert balloon catheter 13.
Autopsy showed entrance of the catheter into a
false medial lumen, a few centimeters above the
bifurcation. The catheter did not re-enter the aortic
lumen; no loss of blood sufficient to account for
death could be demonstrated. Angiography re-
vealed an intimal flap in the descending thoracic
aorta in one more patient analyzed after two years.
Emboli in the femoral arteries could always be
extracted with a size 6 Fogarty catheter.
CARDIOGENIC SHOCK AND SEVERE LEFT VENTRICULAR
FAILURE (TABLE 2 )
Seventy-six patients (34-71 years, mean 55 years;
64 males and 12 females) were treated with IABP.
Sixty-two out of 76 (81%) had an acute anterior
myocardial infarction, 11/76 (15%) had an acute
inferior infarction, and 3/76 (4%) had ECG-
changes suggesting both anterior and inferior
infarction. Forty-two patients (55%) could be
weaned but nine (12%) died within three months of
intractable LVF or ventricular arrhythmias.
Thirty-three patients (43%) survived over three
months; 29 of these are still alive. The majority
(21/29, 72%)~require drugs, but lead active lives
(New York Heart Association class I—II). Of
the 76 patients, 23 had the clinical symptoms of
shock, associated with the haemodynamic criteria
of severe pump failure (PCWP >18mmHg, and
S.W.I. 1200-2000 ml mmHg M"2, MIRU class III-
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Table 2 Seventy-six patients (34-71 years, mean 55 years): 62 AMI; 3 AAfl+PMI; 11 PMI
Total Deaths on IABP Deaths <3 months Survivors >3 months
76 patients
64 a
129
52 < 60 years (68%)
28 CAD >1 year(36%)
36 IABP delay <6 h (47%)
34 patients
30 rf
4 9
20 < 60 years (58%)
18 CAD >1 year (52%)
8IABPdelay<6h(23%)
9 patients
6cf
39
5 < 60 years (55%)
3 CAD >1 year (33%)
2 IABP delays 6 h (22%)
33 patients
28 rf
59
27 < 60 years (81%)
7 CAD >1 year (21%)
26 IABP delays 6 h (78%)
Table 3 Age, IABP delay, CAD > 1 year
Age
< 60 years
> 60 years
Total
r
r
S
20(4)
6(1)
26(5)
«j6h
A
Deaths on
IABP
4(3)
4(3)
8(6)
IABP Delay
Deaths on
<3 months S
2 7(2)
2 7(2)
> 6 h
Deaths on
IABP
16(5)
10(7)
26(12)
Deaths on
<3 months
3
4(3)
7(3)
Total
52(14)
24(14)
76(28)
IV). Fifteen (66%) of these patients could be weaned
and 12 (53%) survived over three months. In con-
trast, of the 53 patients who had clinical and
haemodynamic cardiogenic shock (PCWP
>18mmHg and S.W.I. < 1200 ml mmHgM"2,
MIRU class IV), 27 (51%) could be weaned and
only 21 (40%) survived over three months.
Since these two groups differed only with respect
to S.W.I., they will not be separated in the subse-
quent description.
In six patients with acute mechanical defects and
intractable heart failure, surgery was performed.
Only two of the six patients survived over one year.
One required aneurysmectomy and closure of
ventricular septal defect. The other patient had a
papillary muscle rupture associated with acute
inferior infarction and required mitral valve re-
placement. In both patients surgery could be
postponed for six weeks after the acute event. In the
four patients who died, surgery was performed at an
earlier stage, all four required aneurysmectomy,
and in two mitral regurgitation due to geometrical
LV changes necessitated valve replacement.
Patients who survived over three months were
generally young (27/33, 81% <60 years). Only a
small minority (7/33, 21%) had a history of long-
standing coronary artery disease, and the majority
was treated very promptly with the IABP: 26/33
(78%) were treated with IABP within 6 h of onset of
left ventricular failure (Table 2).
These apparent determinants of outcome: age,
delay of therapy with the IABP and the presence of
longstanding coronary artery disease (CAD
> 1 year), with documented previous infarctions
and/or angina pectoris were related to survival
(Table 3): of the patients younger than 60 years,
20/52 (38%) died during treatment with IABP, 5/52
(10%) died within three months, and 27/52 (52%)
survived over three months. Of the patients older
than 60 years, 14/24 (58%) died during therapy,
4/14 (28%) died within three months and only 6/24
(25%) survived over three months.
Of the 36 patients treated with the IABP within
6 h following onset of shock, eight (22%) died
during therapy, two (6%) died within three months
and 26 (72%) survived over three months.
Of the 40 patients in whom treatment with IABP
was delayed for over 6 h, 26 (66%) died during
treatment, seven (17%) died within three months
and only seven (17%) survived over three months.
Twenty-eight patients had a longstanding history
of coronary artery disease: 18/28 (64%) died during
treatment, 3/28 (11%) died within three months,
and 7/28 (25%) survived over three months.
The subset of patients younger than 60 years,
with IABP instituted within 6 h had a favourable
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Table 4 A ngina at rest despite medical treatment
No. vessels Total IABP
obstructed patients efficacy
MI on Deaths on MI during Deaths during MI Deaths
IABP IABP CABG CABG CABG < 1 month < 1 month
LMCA
3V
2V
IV LAD
LCX
RCA
I
19
14
8
—
1
18
14
8
1 —
1 —
18 2
14 1
Total 42 41 1 — 41
Table 5 Post infant angina at rest despite medical treatment
No. vessels
obstructed
Total
patients
IABP
efficacy
MI on
IABP
Deaths on
IABP CABG
3
MI during
CABG
1
Deaths during
CABG
2
MI
<1 month
2
Deaths
< 1 month
LMCA
3V
2V
1 V LAD
LCx
RCA
8
7
2
7
6
1
•
1 1
1 —
1 —
Total 17 14 — 12 —
outcome. Of the 26 patients with this fortuitous
combination 20 (76%) survived over three months,
and of those dying during treatment 3/4 (75%) had
longstanding coronary artery disease. All patients
older than 60 years with an IABP delay exceeding
6 h died within three months. However 6/10 (60%)
patients older than 60 years treated within 6 h
survived over three months.
ANGINA AT REST REFRACTORY TO MAXIMAL MEDICAL
THERAPY (TABLES 1, 4 AND 5)
Fifty-nine patients with this syndrome were
treated with the IABP. Forty-two had angina at rest
either of new onset or superimposed on previously
stable angina. Seventeen patients had angina at rest,
within two weeks following AMI (post infarct
angina at rest). These will be discussed separately.
Pain relief was prompt in 41/42 (98%) patients
(35-65 years, mean 62 years) after institution of
IABP. In one patient, a 65 year old male, with long-
standing three vessel CAD, symptoms worsened.
This patient developed a non fatal AMI, and was
no longer a candidate for CABG.
Cardiac catheterization showed left main coron-
ary artery (LMCA) obstruction in one patient (3%),
three vessel obstruction in 19 (46%), two vessel
obstruction in 14 (34%) and single vessel obstruc-
tion (all proximal obstruction of the LAD) in eight
patients (19%). Forty-two patients underwent
CABG. Two patients (4%) had an AMI during
surgery; in one of these infarction and subsequent
death may have been attributable to trapping of gas
in a kinked balloon (see complications, Table 8).
Myocardial infarction rate for the whole group
was 11% (5/42): one patient had an AMI despite
IABP, two patients (4%) had an AMI during
CABG, and in two patients (4%) who died within
24 h, an AMI could not be excluded. Total
mortality rate was 7% (3/42): one patient died
during the surgical procedure (2%), two high risk
patients (4%) with three vessel disease, poor left
ventricular function and severe associated disease
(diabetes mellitus) died within 24 h. Of the 38
patients who survived CABG, one had an AMI
within three months, four had mild stable angina
pectoris (NYHA class II). None died (follow-up
three months-five years).
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Table 6 Slowly evolving MI
Sex
M
M
F
M
M
M
M
M
Age
57
30
53
52
56
57
56
41
IABP efficacy resolution
of pain
yes no
+
+
+
+
+
+
+
+
Follow-up
6 months
3 years
2 years
2 years
6 months
2 years
?
2 years
Results
Death at 6 months
NYHAI
NYHA II (LVF)
NYHAI
NYHA II
NYHAI
9
NYHAI
POST INFARCTION ANGINA AT REST REFRACTORY TO
MEDICAL THERAPY (TABLES 1 AND 5)
Within two weeks after sustaining AMI, 17
patients (27-62 years, mean 49 years) had angina at
rest, refractory to medical therapy. After institution
of IABP, pain relief was prompt in 14/17 (83%).
Symptoms worsened despite IABP in three
patients; all three sustained AMI, and were sub-
sequently not operated on. One of these developed
shock and died.
Two other patients were not operated on. One
patient with severe distal CAD was judged inoper-
able. In another patient the IABP was removed
when worsening renal function together with hema-
turia suggested renal infarction (see complications,
Table 8).
Twelve patients underwent CABG. None died,
none developed AMI, three have mild stable angina
(follow-up three months-four years).
Total myocardial infarction rate was 24% (4/17).
Three patients did not respond /to IABP, all
sustained an AMI, and one developed CSMI and
died. He.was a 53 year old male with several earlier
infarctions and poor left ventricular function
(EF<030) and an acute anterior infarction. The
two other patients survived their AMI. One patient
was considered inoperable and had a fatal AMI one
month later. Total mortality rate was 12% (2/17).
There was no surgical mortality in this group.
SLOWLY EVOLVING MYOCARDIAL INFARCTION
(TABLES 1 AND 6 )
Persistence of pain refractory to medical therapy
over a period of 12 h after sustaining AMI, associ-
ated with refractory ventricular arrhythmias, and/
or mild LVF, suggested a slowly evolving AMI in
eight patients (30-57 years, mean 50 years). After
IABP institution, pain relief associated with reduc-
tion in LVF and arrhythmias was prompt in
7/8 (88%). One patient not responding to IABP,
remained limited by chronic LVF and died sud-
denly six months later.
Of the seven patients who did well on IABP, six
were followed up for six months-three years: four
are asymptomatic, one has stable angina pectoris
requiring drugs, one has chronic mild LVF. No
cardiac catheterization was performed in this
group.
Discussion
CARDIOGENIC SHOCK
CSMI has a grave prognosis with medical therapy
alonet25- 26I. IABP combined with cardiac surgery
has been reported to reduce the mortality rate to
55-60%I25'27). IABP alone has reduced the mor-
tality rate to 70-84%(28- Ml. The remarkably good
results at our institution!12-'4] may be partially
attributed to the extension of our indications from
strict CSMI MIRU IV (MIRU IV) to severe LVF
after AMI (MIRU III—IV). A better prognosis is
expected related to a better haemodynamic status.
Our earlier experiences have indicated that
severe LVF, so called 'preshock', is indeed a
precursor to shock. The majority of patients
presenting with a PCWP greater than 18 mmHg
and a S.W.I. (S.I. x MAP) between 1200-2000 ml
mmHg M"2 (MIRU III—IV) progressed rapidly into
irreversible shock MIRU IV with medical therapy
alone. This negative outcome of medical therapy
alone is well demonstrated in the patients with
CSMI III-IV who were candidates for the IABP, but
in whom balloon catheter insertion failed (Table 7):
7/8 (88%) patients died within one month following
medical therapy, and only one patient survived
over one year, but was incapacitated by chronic
LVF (NYHA III). All eight patients had a S.W.I-
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Table 7 Failures to insert balloon catheter
Sex
M
M
M
M
F
M
M
M
F
M
M
M
M
Age
59
58
51
69
44
69
65
64
57
61
60
61
60
Indication IABP Surgery
CSMIIII-1V —
CSMI1II-IV —
CSMI HI-IV —
CSMI HI-IV —
CSMI HI-IV —
CSMI HI-IV —
CSMI HI-IV —
CSMI HI-IV —
Slowly evolving MI —
p.o. CABG —
post infarct
a. p. at rest +
miscellaneous —
miscellaneous —
Follow-up '
lday
20 days
1 year
15 days
lday
lday
2 days
3 days
2 years
1 day
3 years
1 year
1 year
Result
Death at 1 day
Death at 20 days
NYHA III, Death at
1 year
Death at 15 days
Death at 1 day
Death at 1 day
Death at 2 days
Death at 2 days
Death at 2 years
Death at 1 day
NYHA I—II
NYHA II
exceeding 1200, but lower than 2000 ml
mmHg M~2. The limitations of medical therapy
alone in severe LVF and shock after AMI are clear.
Positive inotropic drugs enhance cardiac function
but they act mainly upon normal areas of myo-
cardium(3|l and CSMI is characterized by a massive
loss of myocardium. Post-mortem studies have
documented a myocardial destruction of at least
40% of the left ventricle in patients dying in shock
after AMU26' 321. This degree of myocardial loss
reduces the extent of cardiac muscle responsive to
inotropic agents. By increasing myocardial oxygen
requirement, positive inotropic agents may even
augment myocardial ischaemia. Positive inotropic
agents however can restore normal blood pressure,
and maintain an adequate aortic diastolic blood
pressure, which is the major determinant of
the major determinant of coronary blood flow in
these extreme conditions!2- 31.
Vadodilating agents!30- "• 341, decrease oxygen re-
quirements by reducing afterload and preload,
but if cardiac output does not compensate for the
decreased peripheral resistance, aortic diastolic
blood pressure may drop beyond a critical level.
Our experience indicates that CSMI is princi-
pally a complication of acute anterior myocardial
infarction. This observation may contrast with a
number of studies that did not demonstrate a
relation of shock to location of infarction!32- 351,
but it is in agreement with recent investigations that
demonstrated that impairment of pump function is
greater and the occurrence of shock is more fre-
quent in anterior than in inferior infarctions!2'-31!.
Anterior infarction is related to occlusive disease
of the LAD, which in the majority of instances
supplies a greater quantity of left ventricular
myocardium than either the right or circumflex
arteries. This explains the fact that anterior infarc-
tion is usually quantitatively greater than
inferior!36- "1.
Shock complicating an acute inferior infarction is
usually either associated with acute mechanical
complications!31! (rupture of the posteromedial
papillary muscle, which has a blood supply rela-
tively less adequate than the anterior papillary
muscle, or ventricular septal rupture) or with
extension of infarction to the right ventricle!38- 381,
causing predominant right ventricular infarction
and failure, with a low input of the left ventricle, a
mechanism fundamentally different from cardio-
genic shock complicating acute anterior myo-
cardial infarction, which is caused by extensive
damage to the left ventricular free wall, apex and
inter ventricular septum. This difference has prac-
tical consequences: if a patient is admitted with the
clinical signs of cardiogenic shock and an acute
anterior myocardial infarction, no time should be
wasted and the IABP should be introduced as soon
as possible. In the patient with an acute inferior
infarction presenting with hypotension, oliguria
and an altered sensorium, but without pulmonary
congestion, haemodynamic measurements should
be performed to exclude a right ventricular infarc-
tion, characterized by an elevated right atrial
pressure, little generation of pressure in the right
ventricle and a normal PCWP and a low CO.
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Table 8 Complications of IABP
Duration of IABP
Total no. of patients
Infection of wound
Femoral artery bleeding
Local damage to artery requiring surgery
Ischaemia of leg-acute
Ischaemia of leg-chronic
Dissection of aorta
Kinking of balloon
Thromboembolism
Renal function impairment
Total no. of major complications
Thrombocytopaenia
< 5 days
87
2
3
1
1
2
1
3
1
14
2
5-10 days
34
3
1
1
2
2
4
13
15
>
47
6
4
1
2
6
19
37
10 days Total
168
11
8
2
3
3
4
1
13
1
46
54
Plasma infusions i.v. may increase the pressure
gradient and passive pulmonary flow in this
patient. IABP however reduces left ventricular
afterload, and offers no benefit to such a
patient!38- Ml
Our results are in agreement with those of
others!31-40! that there is a subset of patients with
CSMI in whom prognosis appears to be more
favourable. These are generally young patients,
with their first anterior AMI, and prodromes of
recent onset (<4 weeks). Coronary angiography
frequently shows a proximal single occlusion of the
LAD. At autopsy a proximal thrombotic occlusion
of the LAD is found often with distal patency and
no major arteriosclerotic changes in the other
coronary vessels.
Patients with acute mechanical lesions comprise
another subset. Rupture of a papillary muscle is
relatively rare, and most commonly involves the
posteromedial papillary muscle in inferior myo-
cardial infarction!31!. The anterolateral papillary
muscle may be involved in anterolateral infarction.
In anterior infarction, dilation of the left ventricle
with geometrical changes is probably a more
important contributor to mitral regurgitation.
The clinical differentiation of mitral regurgi-
tation from septal rupture is often difficult. Defini-
tive diagnosis requires right heart catheterization
with analysis of right atrial and ventricular blood
oxygen content. Mitral regurgitation and septal
rupture may occur simultaneously in the same
patient!'"!. Ventricular septal rupture usually in-
volves the lower portion of the muscular septum
and varies in size and number of perforations. Our
current position is that surgery in CSMI should be
limited to patients with definite mechanical lesions:
mitral regurgitation due to papillary muscle rup-
ture, ventricular septal ruptures, and circumscribed
aneurysms. Our surgical experience is very limited
(six patients). In fact only two patients survived:
one had a ruptured papillary muscle and one a
ventricular septal rupture, both being operated on
well over six weeks after the acute event!'3!. A
third subgroup may be constituted by generally
older patients with longstanding CAD and multiple
vessel disease!3'!, in this category, the onset of shock
may be more gradual, possibly explaining the time
delay in treatment with IABP so often encountered
in these patients.
ANGINA PECTORIS AT REST REFRACTORY TO MEDICAL
THERAPY
A detailed descriptive diagnosis is preferable to a
loose use of the term unstable angina or its many
synonyms. The great diversity in definitions and
therapeutic approaches makes it difficult to com-
pare different studies on unstable angina pectoris.
However, some facts clearly emerge from the
studies performed in the past!42"45). First, there
is a sharp decrease in mortality and morbidity
when comparing the studies done before 1970 with
those done after 1970. While the earlier studies
may represent the natural history of unstable
angina pectoris, the later reflect the outcome of
different therapeutic approaches. Second, sub-
groups at high risk of myocardial infarction
and/or sudden death, are constituted (a) by patients
with unstable angina pectoris, superimposed on
stable angina pectoris, or previous infarction(s), (b)
by patients who remain symptomatic after 48 h of
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bedrest and maximal medical therapy!42-«] and (c)
by patients with post infarct refractory angina at
rest!45' 461. Third, obligatory surgery should . be
performed in patients with obstruction of the
LMCAl4']. Fourth, patients with unstable angina
and a very proximal LAD obstruction, and an as
yet uncompromized myocardium seem to consti-
tute a category, in whom surgery should be
obligatory!47]. Fifth, both cardiac catheterization
and CABG have a higher morbidity and mortality
in unstable angina, when compared to stable
angina!42' «!. Sixth, surgical risk is related to cardiac
function, as reflected by the ejection fraction and
the number of vessels diseased!42). Seventh, patients
managed with medical therapy alone, have no
higher mortality rate than those undergoing CABG.
Eighth, the extent of coronary artery disease
determines subsequent return of angina pectoris!24),
and thus the need for elective CABG at a lesser risk
than when under unstable conditions. Immediate
surgery should therefore be restricted to patients
not responding to medical therapy, and patients
with LMCA and proximal LAD obstructions.
Our results indicate a high perioperative mor-
tality in patients with refractory angina pectoris
treated with the IABP (7%). However the series is
small (41 patients), and it should be noted that
death was attributable to intractable diabetes
in two patients. One of these was also at high risk
because of severe three vessel obstructive disease
and poor left ventricular function. In one patient
the IABP may have contributed to death. It should
be stressed that no surgical mortality could be
demonstrated in the 12 patients undergoing CABG
for post infarct angina at rest. When considering the
whole group, surgical mortality is 6% (3/53), still
definitely higher than the mortality for patients
undergoing CABG under more stable conditions
The patients selected for IABP however were
completely refractory to any form of medical
therapy and had rapid progression of their symp-
toms!49!, and they constitute a special 'high risk'
group. We do not recommend a more aggressive
and prophylactic use of the IABP, which may be
unnecessarily hazardous. The introduction of new
drugs may further diminish the need for IABP in
these patients in future.
PERSISTING PAIN AFTER AMI, SUGGESTING SLOWLY
EVOLVING INFARCTION
This series is rather small, there is no control
group, and evidence that we actually reduced
infarct size or the extent of ischaemic injury is
lacking. Prolonged ischaemic pain, with hypo-
tension and/or ventricular arrhythmias is an estab-
lished indication for IABP!50]. However, in these
reports the IABP served as a stabilizing device,
prior to CABG, and was not the definitive method
oftherapy.
Our approach is unique in the sense that the
IABP was used as a definitive therapy, for a fixed
period of time (five days), without contemplating
CABG. The abolition of pain suggests effective
reduction of ischaemia, and we demonstrated that
these patients could be weaned from the device
without recurrence of symptoms, and had no
myocardial infarctions or sudden death during a
follow-up of six months-three years.
COMPLICATIONS OF IABP
Complications of IABP may be grave, and
include arterial and aortic wall damage with or
without gangrene of the leg distal to catheter
insertion, embolization, thrombocytopaenia, bal-
loon rupture, trapping of gas in a kinked balloon,
and infectiont'J-2^ 51-55].
In our experience, prolonged use of IABP was
associated with more complications!13!, notably
thromboembolic processes, vascular lesions and
thrombocytopaenia. However, no relationship be-
tween fatal complications and duration of IABP
was found. All three lethal complications were
related to catheter insertion. Dissection of the aorta
is the major complication of catheter insertion, and
may go completely unnoticed, with effective intra-
mural balloon pumping!28!.
Conclusion
Cardiogenic shock and severe left ventricular
failure, principally complicating acute anterior
myocardial infarction, can be successfully treated
with IABP alone. Delay of treatment is the major
determinant of prognosis, which further depends on
age and history of coronary artery disease. Surgery
is indicated when mechanical defects exist, but has
only limited success.
When medical therapy is ineffective, rapid insti-
tution of IABP ensures immediate pain relief to
patients with angina pectoris at rest refractory to
optimal medical therapy.
Even in patients with post infarct unstable angina
subsequent coronary artery bypass grafting can be
performed safely with good prognosis for survival
and symptoms.
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IABP abolishes symptoms when persistent pain,
ventricular irritability and mild LVF suggest a
slowly evolving myocardial infarction.
We are most grateful to Miss Anneke Wagenaar for her
technical assistance.
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